A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.

Objective: To develop a multi‐stakeholder, consensus‐based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. Methods: A two‐round Delphi survey was conducted with a multid...

Descripción completa

Detalles Bibliográficos

Publicado en:	Health Expectations Vol. 29; no. 2; pp. 1 - 10
Autores principales:	Zhao, Jie, Hu, Youhong, Zhu, Yumei, Wu, Bin, Hu, Ming, Li, Min, Liang, Yan, Li, Jia, Qiao, Gaoxing, Fan, Xintong, Yan, Helei, Wang, Xiaoyun, Zheng, Zhixin, Zhang, Xiaodan, Li, Junwei, Lou, Tingting, Ma, Yuchen
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell Apr2026
Acceso en línea:	Ver este registro en EBSCOhost